SI1115725T1 - Tetrahydropyridoethers - Google Patents

Tetrahydropyridoethers

Info

Publication number
SI1115725T1
SI1115725T1 SI9930207T SI9930207T SI1115725T1 SI 1115725 T1 SI1115725 T1 SI 1115725T1 SI 9930207 T SI9930207 T SI 9930207T SI 9930207 T SI9930207 T SI 9930207T SI 1115725 T1 SI1115725 T1 SI 1115725T1
Authority
SI
Slovenia
Prior art keywords
tetrahydropyridoethers
naphthyridine
imidazo
methoxyethoxy
tetrahydro
Prior art date
Application number
SI9930207T
Other languages
English (en)
Slovenian (sl)
Inventor
Stefan Postius
Wolfgang-Alexander Simon
Gerhard Grundler
Guido Hanauer
Reinhard Huber
Wolfgang Kromer
Ernst Sturm
J�rg SENN-BILFINGER
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of SI1115725T1 publication Critical patent/SI1115725T1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SI9930207T 1998-09-23 1999-09-17 Tetrahydropyridoethers SI1115725T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP98117988 1998-09-23
DE19843504 1998-09-23
PCT/EP1999/006899 WO2000017200A1 (en) 1998-09-23 1999-09-17 Tetrahydropyridoethers
EP99948776A EP1115725B1 (en) 1998-09-23 1999-09-17 Tetrahydropyridoethers

Publications (1)

Publication Number Publication Date
SI1115725T1 true SI1115725T1 (en) 2003-06-30

Family

ID=26049024

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9930207T SI1115725T1 (en) 1998-09-23 1999-09-17 Tetrahydropyridoethers

Country Status (31)

Country Link
US (4) US6436953B1 (cs)
EP (1) EP1115725B1 (cs)
JP (1) JP4145492B2 (cs)
KR (1) KR100668400B1 (cs)
CN (2) CN100506821C (cs)
AT (1) ATE231862T1 (cs)
AU (1) AU763463B2 (cs)
BG (1) BG65195B1 (cs)
BR (1) BR9914044A (cs)
CA (1) CA2344251A1 (cs)
CZ (1) CZ292335B6 (cs)
DE (1) DE69905178T2 (cs)
DK (1) DK1115725T3 (cs)
EA (1) EA005377B1 (cs)
EE (1) EE04677B1 (cs)
ES (1) ES2191464T3 (cs)
GE (1) GEP20032926B (cs)
HK (1) HK1038360B (cs)
HR (1) HRP20010224A2 (cs)
HU (1) HUP0102990A3 (cs)
ID (1) ID28896A (cs)
IL (2) IL142063A0 (cs)
NO (1) NO317304B1 (cs)
NZ (1) NZ510610A (cs)
PL (1) PL193616B1 (cs)
PT (1) PT1115725E (cs)
RS (1) RS50145B (cs)
SI (1) SI1115725T1 (cs)
SK (1) SK285165B6 (cs)
TR (1) TR200100805T2 (cs)
WO (1) WO2000017200A1 (cs)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000017200A1 (en) 1998-09-23 2000-03-30 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrahydropyridoethers
ES2199810T3 (es) 1999-04-17 2004-03-01 Altana Pharma Ag Haloalcoxi-imidazonaftiridinas.
CA2721484A1 (en) * 1999-05-12 2000-11-12 President And Fellows Of Harvard College Dopamine transporter imaging agents
JP2003528878A (ja) * 2000-03-29 2003-09-30 アルタナ ファルマ アクチエンゲゼルシャフト イミダゾピリジン誘導体のプロドラッグ
US6696461B2 (en) * 2000-03-29 2004-02-24 Altana Pharma Ag Tricyclic imidazopyridines
US6869949B2 (en) 2000-10-25 2005-03-22 Altana Pharma Ag Polysubstituted imidazopyridines as gastric secretion inhibitors
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
CN1496259A (zh) * 2001-03-08 2004-05-12 新用途
ATE336493T1 (de) 2001-08-02 2006-09-15 Altana Pharma Ag Tricyclische epoxide
US20040235882A1 (en) * 2001-08-03 2004-11-25 Jorg Senn-Bilfinger Amino-substituted imidazopyridines for the treatment of gastrointestial diseases
IL159555A0 (en) * 2001-08-03 2004-06-01 Altana Pharma Ag Alkyl-substituted imidazopyridine derivatives and pharmaceutical compositions containing the same
PL371413A1 (en) 2002-02-15 2005-06-13 Altana Pharma Ag Tricyclic n-acyl compounds
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
HRP20041160A2 (en) * 2002-05-07 2005-08-31 Altana Pharma Ag Novel combination for the treatment of airway disorders
EA008304B1 (ru) 2002-11-19 2007-04-27 Алтана Фарма Аг 8-замещённые имидазопиридины
DE60323138D1 (de) 2002-12-12 2008-10-02 Nycomed Gmbh Kombinationsarzneimittel aus r,r-formoterol und ciclesonide
EP1585516A2 (en) * 2002-12-20 2005-10-19 ALTANA Pharma AG 8-trialkylsiloxy-2-methyl-9-phenyl-7-oxo-7,8,9,10-tetrahydroimidazo[1,2-h][1,7]naphthyridines
AU2004212337A1 (en) * 2003-02-17 2004-08-26 Altana Pharma Ag Imidazopyridines containing combinations and their use in treating gastrointestinal inflammatory disorders
PT1606261E (pt) 2003-03-10 2010-01-11 Nycomed Gmbh Novo processo para a preparação de roflumilast
TW200503783A (en) * 2003-04-11 2005-02-01 Altana Pharma Ag Oral pharmaceutical preparation for proton pump antagonists
SA04250092B1 (ar) * 2003-05-14 2008-05-04 التانا فاروا ايه جي مركب وسيط جديد لتحضير مركبات إيميدازوبيريدين imidazopyridines فعالة علاجياً
JP2006528231A (ja) * 2003-05-27 2006-12-14 アルタナ ファルマ アクチエンゲゼルシャフト プロトンポンプ阻害剤と胃腸運動性を変更する化合物との医薬品組合せ物
CA2537182A1 (en) * 2003-08-29 2005-03-10 Dynogen Pharmaceuticals, Inc. Compositions useful for treating gastrointestinal motility disorders
PT1670482E (pt) 2003-09-16 2014-03-12 Takeda Gmbh Utilização de ciclesonida para o tratamento de doenças respiratórias
WO2005041961A1 (en) * 2003-11-03 2005-05-12 Astrazeneca Ab Imidazo [1,2-a] pyridine derivatives for the treatment of silent gastro-esophageal reflux
AU2004298453A1 (en) 2003-12-19 2005-06-30 Altana Pharma Ag Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives
AR047605A1 (es) * 2004-02-17 2006-01-25 Altana Pharma Ag Imidazopiridinas triciclicas e intermediarios en la sintesis de las mismas,sus procesos de preparacion,composiciones farmaceuticas que los contienen y usos.
ES2373672T3 (es) 2004-09-03 2012-02-07 Yuhan Corporation Derivados de pirrolo[2,3-c]piridina y procesos para su preparación.
MX2007002219A (es) 2004-09-03 2007-05-04 Yuhan Corp Derivados de pirrolo [3,2-b ] piridina y procesos para su preparacion.
EP1784402B1 (en) 2004-09-03 2011-08-03 Yuhan Corporation PYRROLO[3,2-c]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF
DK1861074T3 (da) * 2005-03-16 2013-07-29 Takeda Gmbh Smagsmaskeret doseringsform indeholdende roflumilast
EP2080513A1 (en) * 2008-01-16 2009-07-22 Schraermeyer, Ulrich, Prof. Dr. rer. nat Tetrahydropyridoethers for treatment of AMD
CN102470126A (zh) * 2009-07-09 2012-05-23 拉夸里亚创药株式会社 用于治疗与异常肠胃运动有关的疾病的酸泵拮抗剂
WO2012027240A1 (en) * 2010-08-23 2012-03-01 Schering Corporation Fused tricyclic inhibitors of mammalian target of rapamycin
CA2874988C (en) * 2012-06-15 2016-05-24 Bio-Pharm Solutions Co., Ltd. Phenylalkyl sulfamate compound and muscle relaxant composition comprising the same
EP3054949A1 (en) 2013-10-08 2016-08-17 Katairo GmbH Tetrahydropyridoethers for the treatment of stargardt's disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468400A (en) * 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines
FI900219A0 (fi) 1987-07-16 1990-01-15 Byk Gulden Lomberg Chem Fab Nya diazoler.
SE9401197D0 (sv) * 1994-04-11 1994-04-11 Astra Ab Active compounds
AU702166B2 (en) * 1994-07-28 1999-02-18 Byk Gulden Lomberg Chemische Fabrik Gmbh Acylimidazopyridines
WO1998042707A1 (en) * 1997-03-24 1998-10-01 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrahydropyrido compounds
EE03771B1 (et) * 1997-03-24 2002-06-17 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrahüdropüridoühendid, neid sisaldav ravim ja nende kasutamine
WO2000017200A1 (en) * 1998-09-23 2000-03-30 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrahydropyridoethers

Also Published As

Publication number Publication date
BG105270A (en) 2001-11-30
SK285165B6 (sk) 2006-07-07
US7105676B2 (en) 2006-09-12
ID28896A (id) 2001-07-12
US20020169320A1 (en) 2002-11-14
PL346617A1 (en) 2002-02-25
EE04677B1 (et) 2006-08-15
JP4145492B2 (ja) 2008-09-03
KR100668400B1 (ko) 2007-01-17
EA200100315A1 (ru) 2001-10-22
DE69905178D1 (de) 2003-03-06
CZ20011082A3 (cs) 2001-09-12
RS50145B (sr) 2009-03-25
BG65195B1 (bg) 2007-06-29
IL142063A0 (en) 2002-03-10
HK1038360A1 (en) 2002-03-15
NO317304B1 (no) 2004-10-04
PT1115725E (pt) 2003-06-30
YU21401A (sh) 2004-03-12
JP2002526499A (ja) 2002-08-20
CN100506821C (zh) 2009-07-01
GEP20032926B (en) 2003-03-25
ATE231862T1 (de) 2003-02-15
KR20010075223A (ko) 2001-08-09
CN1560055A (zh) 2005-01-05
US6696460B2 (en) 2004-02-24
HUP0102990A2 (hu) 2002-01-28
ES2191464T3 (es) 2003-09-01
IL142063A (en) 2007-10-31
US20040162310A1 (en) 2004-08-19
BR9914044A (pt) 2001-12-04
WO2000017200A1 (en) 2000-03-30
AU763463B2 (en) 2003-07-24
CA2344251A1 (en) 2000-03-30
HUP0102990A3 (en) 2002-09-30
CN1155598C (zh) 2004-06-30
NO20011243L (no) 2001-03-12
HRP20010224A2 (en) 2002-04-30
DE69905178T2 (de) 2003-07-17
EA005377B1 (ru) 2005-02-24
NO20011243D0 (no) 2001-03-12
US6436953B1 (en) 2002-08-20
EP1115725A1 (en) 2001-07-18
PL193616B1 (pl) 2007-02-28
CZ292335B6 (cs) 2003-09-17
EP1115725B1 (en) 2003-01-29
DK1115725T3 (da) 2003-06-23
SK3992001A3 (en) 2001-12-03
TR200100805T2 (tr) 2001-08-21
US7393860B1 (en) 2008-07-01
NZ510610A (en) 2003-07-25
HK1038360B (en) 2003-05-16
CN1319101A (zh) 2001-10-24
EE200100172A (et) 2002-06-17
AU6192099A (en) 2000-04-10

Similar Documents

Publication Publication Date Title
PL346617A1 (en) Tetrahydropyridoethers
ZA200108855B (en) Method for the preparation of citalopram.
ZA200108854B (en) Method for the preparation of citalopram.
EE04676B1 (et) Imidasopridiini derivaadid, mis inhibeerivad maohappesekretsiooni, protsess nende valmistamiseks ning nende kasutamine
IL142346A0 (en) Method for the preparation of citalopram
IL145615A0 (en) Method for the preparation of citalopram
GB2360281B (en) Method for the preparation of citalopram
ZA200206699B (en) Method for the preparation of citalopram.
ZA99493B (en) Method for the isolation of nucleic acid.
AU7902400A (en) Method for the preparation of 5-carboxyphthalide
HUP0203840A3 (en) Method for the preparation of citalopram
ZA973400B (en) Method for the manufacture of brushes.
CY2392B1 (en) Method for the preparation of alpha-bromolactam derivatives.
EP0669361A3 (en) Process for the preparation of polyheterosiloxanes.
HUP0200169A3 (en) Method for the preparation of citalopram
AU1130901A (en) Method for the preparation of 5-carboxyphthalide
ZA200102822B (en) Method for the preparation of citalopram.
ZA200106687B (en) Method for the preparation of citalopram.
AUPQ075599A0 (en) Method for direct electromagnetic-ultrasonic measurements of the permeability ofrocks
SI1123284T1 (en) Method for the preparation of citalopram
ZA99354B (en) Method of making sulfanatophenyl substituted porphines.